Business Combinations (NPS Pro Forma Information) (Details) - NPS Pharma - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2015
Business Acquisition [Line Items]
Revenues	$ 1,655,000,000	$ 4,730,900,000
Net income from continuing operations	$ 479,100,000	$ 1,005,600,000
Net income from continuing operations per share - basic (in usd per share)	$ 0.81	$ 1.70
Net income from continuing operations per share - diluted (in usd per share)	$ 0.81	$ 1.69
Increase/(decrease) to net income to reflect acquisition related costs	$ 2,000,000	$ 105,200,000
Increase/(decrease) to net income to reflect the fair value adjustment to acquisition date inventory.	4,200,000	13,400,000
An adjustment to increase amortization of intangible assets	$ 0	$ (21,200,000)